Eos: Reading the pathogenic cell By Steve Edelson
Staff Writer

Many genomics companies are focused on a technology platform to generate various forms of data for clients, and not on developing therapeutics for their own account. But Eos Biotechnology Inc. is combining biological systems with its genomics and bioinformatics technologies to develop immunotherapeutics to treat cancer, cardiovascular and autoimmune disorders.